FindTrial
Sign In

Analysis of the drug resistance of A20 gene and NLRP3 gene in the treatment of juvenile idiopathic arthritis

Analysis of the drug resistance of A20 gene and NLRP3 gene in the treatment of juvenile idiopathic arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17013687
Enrollment
Unknown
Registered
2017-12-05
Start date
2018-01-06
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile idiopathic arthritis

Interventions

Case series:biological agents

Sponsors

the Children's Hospital ofAffiliated to Medical University Of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnostic criteria for juvenile idiopathic arthritis; 2. use biological agents

Exclusion criteria

Exclusion criteria: Irregular follow-up

Design outcomes

Primary

MeasureTime frame
A20 and NLRP3 genes;—

Countries

China

Contacts

Public ContactTangxuemei

the Children's Hospital ofAffiliated to Medical University Of Chongqing

tangxuemei2008@163.com+86 23 63632554

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026